Research Participant Registry Join Now! Learn More
Immune System/Infections

If you are interested in hearing more about one or more of the studies listed below, and you are already a Registry participant, please contact the Research Participant Registry at 1-866-438-8230 or via e-mail If you are not already a Registry participant, you can join now!

Cold Sore Research Study University of Pittsburgh PRO12060492B
Do you have a current cold sore? If so, you may be eligible to participate in a study to help researchers understand what happens to cognitive processes over time in people who are exposed to, or who are not exposed to, the herpes simplex virus-1. Participation involves 2 visits, and includes the donation of a blood sample and other tests. Compensation provided.

ACTG A5308 University of Pittsburgh_PRO12100377
Are you age 18 or older and HIV-infected? Has your viral load been less than 500 for the past 2 years? If so, and if you have never taken HIV medications, you may be eligible to participate in a study to see if taking HIV medication reduces immune activation in people who have HIV but show no symptoms. All participants will receive Complera through the study for 1-2 years.

“Feel My Best” research study University of Pittsburgh_PRO09020289
Do you have lupus? Are you experiencing low mood, stress or loss of interest in activities? If so, you may be eligible to participate in study that seeks to see how useful Supportive Counseling and Mind-Body Skills Training are for improving mood and stress symptoms in individuals with Systemic Lupus Erythematosus. Compensation provided.

ACTG A5294 (BIRTH) University of Pittsburgh_PRO12010297
Are you at least 18 years of age? Do you have HIV and Hepatitis C (HCV)? If so, and if your HIV viral load is less than 50,000 and your CD4 count is more than 200, you may be eligible to participate in a study to see if adding a new drug to standard anti-HCV treatment is safe and whether it will help people with both HIV and HCV better fight their HCV. Travel-related costs reimbursed.

ACTG A5258 University of Pittsburgh_PRO10120420
Are you a HIV infected man or woman between the ages of 18 and 65 years old? If so, you may be eligible to participate in a study to learn how well chloroquine, a medication approved by the FDA to treat malaria, reduces the level of activated CD8 T cells. Increased activation of CD8 T cells has been associated with progression of HIV disease. This study will take up about 28 weeks to complete.

Anal HPV in IBD Study University of Pittsburgh_PRO11050042
Are you at least 18 years of age? Have you been diagnosed with Inflammatory Bowel Disease (IBD), and are you being considered to start a medication for IBD that suppresses the immune system? If so, you may be eligible to participate in this study to see if individuals with IBD have increased risk of Human Papillomavirus (HPV) detection or HPV-associated dysplasia. Participants will be compensated.

MTN-017 University of Pittsburgh_PRO12080047
Are you a HIV-negative man or transgender woman who is age 18 or older? Have you had at least one experience of receptive anal sex in the last 90 days? If so, you may be eligible to participate in a study that is looking at the safety and acceptability of Truvada tablets and tenofovir microbicide gel. Participation lasts approximately 8 months and involves 10 study visits. Compensation provided.

This website is maintained by the Clinical and Translational Science Institute. If you have any technical difficulty please submit your help request here.
© Office of the Senior Vice Chancellor for the Health Sciences, University of Pittsburgh. All rights reserved.
Last Update 3/17/2011